<DOC>
	<DOCNO>NCT01494402</DOCNO>
	<brief_summary>The purpose study assess bioequivalence D961S esomeprazole/buffered ASA , safety , tolerability esomeprazole combination ASA pharmacokinetics ( PK ) D961S , esomeprazole buffer ASA follow repeat administration healthy male Japanese subject .</brief_summary>
	<brief_title>Study Assess Bioequivalence Between D961S Esomeprazole/Buffered Acetylsalicylic Acid ( ASA ) Japanese Healthy Male Subjects</brief_title>
	<detailed_description>A Phase I , Open label , Randomized , Single center , 2 way Crossover Bioequivalence Study Comparing D961S ( Fixed-dose Combination Capsule Esomeprazole 20 mg Acetylsalicylic Acid 81 mg ) Free Combination Esomeprazole Capsule 20 mg + Buffered Acetylsalicylic Acid Tablet 81 mg After Repeated Oral Administration Japanese Healthy Male Subjects</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy Japanese male 2045 year age Classified homoEM Negative HIV , Hepatitis B , Hepatitis C syphilis Body Mass Index ( BMI=weight/height2 ) 1927 ( kg/m2 ) Body weight 5085 kg Significant clinical illness 2 week precede preentry visit randomization Past present cardiac , renal , hepatic , neurological gastrointestinal disease Need concomitant medication study Past present NSAIDs induce asthma History bleeding diathesis</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Healthy volunteer , Japanese male , homo-EM</keyword>
</DOC>